IMSAInternational Medical Sciences Academy

JIMSA › Vol 29 No 2 · April–June 2016

Update · pages 99–102

Simultaneous Pancreas-Kidney Transplantation to Treat End-Stage Renal Disease and Diabetes Mellitus

Anshuman Sood, Maria Abou Nader, Yoav J. Dangoor, David N. Hakim, Nadey S. Hakim

Cite this article

Anshuman Sood, Maria Abou Nader, Yoav J. Dangoor, David N. Hakim, Nadey S. Hakim. Simultaneous Pancreas-Kidney Transplantation to Treat End-Stage Renal Disease and Diabetes Mellitus. J Int Med Sci Acad. 2016;29(2):99–102.

Opening of the article

Type I Diabetes Mellitus (TIDM), a mostly genetically determined disease, is an important economic and health burden as it leads to long-term complication eventually resulting in end stage renal disease (ESRD). Today, an allogeneic pancreas transplant coalesced with a kidney transplant i.e. simultaneous pancreas kidney transplantation (SPK) has the potential of rendering a Type I diabetic patient completely independent from both insulin and dialysis treatment while reducing further progression of the diabetes and its associated complications. Simultaneous pancreas-kidney transplantation is the most common method for pancreas transplantation.

Published April–June 2016 · Free to read